--- title: "CIPLA Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search CIPLA recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/cipla/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # CIPLA recall records **0** reported ongoing 7 records in this archive. Latest source date Jul 7, 2023. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Jul 7, 2023 FDA company announcement ### [Cipla: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation)](https://isitonrecall.com/recall/fdapress-d70c8614d54531f4-cipla-albuterol-sulfate-inhalation-aerosol-90-mcg-200-metered-inhalation/) Failure to deliver the recommended dose Not supplied Reported terminated Distribution: The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm. The prod... [Official source for Cipla: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation)](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200) Sep 29, 2022 FDA drug enforcement ### [Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-Dose Vials per pouch, NDC 69097-168-48; 60 (12 x 5) x 2 mL S...](https://isitonrecall.com/recall/fda-drug-d-1550-2022-arformoterol-tartrate-inhalation-solution-15-mcg-2ml-2-ml-sterile-unit-dose-vial-packaged-in-5-x-2-m/) Lack of Assurance of Sterility: environmental monitoring failure. Class II Reported terminated Distribution: Product was distributed nationwide to distributors/wholesalers who may have further distributed the product. [Official source for Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1550-2022%22) Sep 15, 2022 FDA drug enforcement ### [Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd.,...](https://isitonrecall.com/recall/fda-drug-d-1545-2022-budesonide-inhalation-suspension-0-25mg-2ml-for-inhalation-only-rx-only-1-envelope-x-five-2-ml-singl/) Lack of Assurance of Sterility Class II Reported terminated Distribution: Nationwide in the USA and Puerto Rico [Official source for Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1545-2022%22) Aug 22, 2022 FDA drug enforcement ### [Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecuticals, Inc., Boca Raton, FL 33432, NDC 76282-708-50.](https://isitonrecall.com/recall/fda-drug-d-1498-2022-difluprednate-ophthalmic-emulsion-0-05-5-ml-bottle-rx-only-manufactured-for-exelan-pharmecuticals-in/) Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. Class II Reported terminated Distribution: Nationwide in the USA [Official source for Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecut...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1498-2022%22) Aug 22, 2022 FDA drug enforcement ### [Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.](https://isitonrecall.com/recall/fda-drug-d-1499-2022-difluprednate-ophthalmic-emulsion-0-05-5-ml-bottle-rx-only-manufactured-by-cipla-ltd-india-manufactu/) Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. Class II Reported terminated Distribution: Nationwide in the USA [Official source for Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1499-2022%22) Aug 2, 2022 FDA drug enforcement ### [Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 6909...](https://isitonrecall.com/recall/fda-drug-d-1328-2022-difluprednate-ophthalmic-emulsion-0-05-for-ophthalmic-use-only-sterile-5-ml-bottles-manufactured-by/) Lack of Assurance of Sterility: Complaints received of defective container closure. Class II Reported terminated Distribution: Nationwide in the USA [Official source for Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufact...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1328-2022%22) Jul 14, 2022 FDA drug enforcement ### [Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34, Verna Industrial area, Verna - Goa, 403...](https://isitonrecall.com/recall/fda-drug-d-1283-2022-difluprednate-ophthalmic-emulsion-0-05-5ml-bottles-rx-only-mfd-by-cipla-ltd-india-at-m-s-indoco-reme/) Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. Class II Reported terminated Distribution: Nationwide in the USA [Official source for Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1283-2022%22) ## Reasons in these listed records - Failure to deliver the recommended dose - Lack of Assurance of Sterility: environmental monitoring failure. - Lack of Assurance of Sterility - Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. These examples come from this result page and are not a ranking of every recall reason. ## Checking CIPLA ### Is there a recall on cipla right now? This archive contains 7 records, including 0 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search CIPLA](https://isitonrecall.com/check/?q=CIPLA) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)